Liquidia Corporation (LT4.F)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
74.98-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+362.8%
The outlook
Liquidia Corporation currently reads as bullish based on above its 50- & 200-day averages, 92% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Market cap
$6.67B
52-wk high
80.38
52-wk low
15.16
50-day avg
62.79
200-day avg
38.68
Trailing P/E
499.9